市場調査レポート

世界の止血診断市場の将来展望:新たな市場機会と事業拡張戦略

2016-2020 Global Coagulation Testing Market: Reagent and Instrument Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US

発行 Venture Planning Group 商品コード 232600
出版日 ページ情報 英文 650 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
世界の止血診断市場の将来展望:新たな市場機会と事業拡張戦略 2016-2020 Global Coagulation Testing Market: Reagent and Instrument Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
出版日: ページ情報: 英文 650 Pages
概要

当レポートでは、主要7カ国における止血診断関連市場について分析し、世界全体の技術・市場の最新動向、各国市場の状況(事業環境、市場構造、市場規模・成長率、主なサプライヤー)と今後10年間の動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • 主な定期的・特殊止血検査
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出欠時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー(全43種)
  • 主要な体外診断技術と潜在的な用途
    • 発色基質
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • DNAプローブ
    • 人工知能
    • ドライケミストリー
    • バイオセンサー
  • 世界市場の概況
    • 事業環境
    • 市場構造
    • 市場規模・成長
    • ポイントオブケア(POC)検査市場

フランス市場

ドイツ市場

イタリア市場

日本市場

スペイン市場

英国市場

米国市場

主な製品開発機会

分散検査製品の設計基準

代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業評価

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCO18075

Complete report $34,500 DataPack (test volumes, sales forecasts, supplier shares) $21,100.

Summary

This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.

The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others. Geographic Coverage France
- Germany
- Italy
- Japan
- Spain
- UK
- USA Market Segmentation Analysis Sales and Market Share Analysis Sales and market shares of major instrument and reagent suppliers. Competitive Assessments Extensive strategic profiles of major suppliers and emerging market entrants. Market Segmentation Analysis Comprehensive market segmentation analysis, including:      - Hospitals      - Commercial/Private Laboratories      - Physician Offices      - Ambulatory Care Centers Test volume forecasts  for over 40 major procedures,
by country and market segment. Current and Emerging Products Review of established and emerging procedures. Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers. Technology Review Analysis of current and emerging technologies and their potential market applications. Comprehensive lists of companies developing or marketing new technologies and products by test. Worldwide Market Overview Estimates of facilities performing coagulation tests by country. Test volume and sales projections by country. Strategic Recommendations Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentativenprices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 650 pages and 150 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Routine and Special Hemostasis Tests
    • 1. Introduction
    • 2. Activated Partial Thromboplastin Time (APTT)
    • 3. Alpha-2 Antiplasmin
    • 4. Antithrombin III
    • 5. Bleeding Time
    • 6. D-Dimer
    • 7. Ethanol Flocculation Test
    • 8. Euglobulin Lysis
    • 9. Factor Assays
      • a. Introduction
      • b. Factor II
      • c. Factor V/Factor V Leiden
      • d. Factor VII
      • e. Factor VIII
      • f. Factor IX
      • g. Factor IXa
      • h. Factor X (Stuart Factor)
      • i. Factor Xa
      • j. Factor XI
      • k. Factor XII
      • l. Factor XIII
    • 10. Fibrin Degradation Products
    • 11. Fibrinogen
    • 12. Heparin
    • 13. Hirudin
    • 14. Hypercoagulability and Thrombosis
    • 15. Lipoprotein a
    • 16. Plasmin
    • 17. Plasminogen
    • 18. Plasminogen Activator Inhibitor (PAI)
    • 19. Platelet Function Tests
    • 20. Platelet Aggregation
    • 21. Proteins C and S
    • 22. Prothrombin Fragment 1.2
    • 23. Prothrombin Time (PT)
    • 24. Reptilase Time
    • 25. Thrombin Time
    • 26. Tissue-Type Plasminogen Activator (t-PA)
    • 27. Von Willebrand's Factor
  • B. Instrumentation Review
    • Introduction
    • Benk Hemolab
    • Benk TRT Thrombotimer
    • Bio/Data MCA 310
    • Bio/Data MCA 210
    • Bio/Data PAP-4C D/4D/4C
    • Cardiovascular Diagnostics COAG
    • Diagnostica Stago STA Compact
    • Diagnostica Stago STA-R
    • Diagnostica Stago Star 4/8
    • Helena Laboratories Cascade 480
    • Helena Laboratories Cascade M
    • Helena Laboratories PACKS-4
    • Helena THOR
    • Instrumentation Laboratory ACL 100 and 1000 series
    • Instrumentation Laboratory ACL6000
    • Instrumentation Laboratory ACL7000
    • Instrumentation Laboratory ACL9000
    • Instrumentation Laboratory Electra 1000C
    • Instrumentation Laboratory Electra 1400C
    • Instrumentation Laboratory Electra 1600/C
    • Instrumentation Laboratory Electra 1800C
    • Instrumentation Laboratory Futura
    • ITC Hemochron 8000
    • Roche Diagnostics CoaguChek
    • Siemens BCS
    • Siemens BCT
    • Siemens BF II/Fibrintimer Series
    • Sysmex CA-50
    • Sysmex CA-500
    • Sysmex CA-1500
    • Sysmex CA-5000/CA-1000
    • Sysmex CA-6000
    • Sysmex CA-7000
    • Teco Coatron II/Jr./AccuStasis 5000
    • Trinity Biotech Amax CS190
    • Trinity Biotech Amax CS400
    • Trinity Biotech Coag-A-Mate Max
    • Trinity Biotech KC 40, 4A, 1A Series
    • Trinity Biotech MDA 180
    • Trinity Biotech Coag-A-Mate MTX
    • Trinity Biotech Coag-A-Mate RA4
    • Trinity Biotech Coag-A-Mate XC/Plus
    • Trinity Biotech Coag-A-Mate XM
  • C. Major in Vitro Diagnostic Technologies and Their Potential Applications
    • 1. Chromogenic Substrates
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Applications
      • b. Technological Principle
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Dot Immunobinding Assays
        • Capillary Immunoassays
        • Enzyme Amplification
        • Electrochemical Immunoassay
      • d. Fluorescent Immunoassays
        • Fluorescence Polarization
        • Time-Resolved Pulse Fluorescence
        • Fluorescence Lifetime
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microcomputers
    • 5. Automation
    • 6. Robotics
    • 7. DNA Probes
      • a. Overview
      • b. Amplification Methods
        • PCR
        • Ligase Chain Reaction
        • Branched DNA
        • Q-Beta Replicase
        • NASBA
        • SDA
        • 3 SR
        • HPA
        • Two-Tiered System
        • LAT
    • 8. Artificial Intelligence
    • 9. Dry Chemistry
    • 10. Biosensors
  • D. Worldwide Market Overview
    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth
    • 4. POC Testing Market

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

UK

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

USA

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Industry Consolidation
    • 4. Managed Care
    • 5. Hospitals
    • 6. Admissions
    • 7. Length of Stay
    • 8. Industry Diversification
    • 9. Physician Demographics
    • 10. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 11. Laboratory Regulations
  • C. Market Structure
    • 1. Centralized Testing
      • a. Hospitals
      • b. Commercial laboratories
    • 2. Decentralized Testing
      • a. Physician Offices/Group Practices
      • b. Point-of-Care Testing
      • c. Home/Self Testing
      • d. Other Decentralized Testing Locations
  • D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Worldwide, All Market Segments, Laboratories Performing Hemostasis Tests By Country, 2010
  • Worldwide, All Market Segments, Total Hemostasis Test Volume By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Reagent Market By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Instrument Market By Country, 2010-2020
  • Worldwide, All Market Segments, Total Hemostasis Diagnostics Market By Country, 2010-2020
  • Executive Summary Table: France, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • France, Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • France, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • France, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • France, Hospital Laboratories Average Daily Test Volume, 2010
  • France, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • France, Total Hemostasis Test Volume By Market Segment, 2010-2020
  • France, All Market Segments Hemostasis Test Volume, 2010-2020
  • France, Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • France, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • France, Hemostasis Reagent Market By Market Segment, 2010-2020
  • France, Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • France, Hemostasis Instrument Market By Market Segment, 2010-2020
  • France, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • France, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • France, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • France, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • France, Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
  • Executive Summary Table: Germany, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • Germany, Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • Germany, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • Germany, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • Germany, Hospital Laboratories Average Daily Test Volume, 2010
  • Germany, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • Germany, Physician Offices/Group Practice Average Daily Test Volume, 2010
  • Germany, Total Hemostasis Test Volume By Market Segment, 2010-2020
  • Germany, All Market Segments Hemostasis Test Volume, 2010-2020
  • Germany, Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • Germany, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • Germany, Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
  • Germany, Hemostasis Reagent Market By Market Segment, 2010-2020
  • Germany, Major Suppliers of Hemostasis Reagents, Estimated Sales and Market Shares, 2010
  • Germany, Hemostasis Instrument Market By Market Segment, 2010-2020
  • Germany, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • Germany, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • Germany, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • Germany, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • Germany, Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
  • Executive Summary Table: Italy, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • Italy, Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • Italy, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • Italy, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • Italy, Hospital Laboratories Average Daily Test Volume, 2010
  • Italy, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • Italy, Total Hemostasis Test Volum By Market Segment, 2010-2020
  • Italy, All Market Segments Hemostasis Test Volume, 2010-2020
  • Italy, Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • Italy, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • Italy, Hemostasis Reagent Market By Market Segment, 2010-2020
  • Italy, Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • Italy, Hemostasis Instrument Market By Market Segment, 2010-2020
  • Italy, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • Italy, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • Italy, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • Italy, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • Italy, Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
  • Executive Summary Table: Japan, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • Japan, Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • Japan, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • Japan, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • Japan, Hospital Laboratories Average Daily Test Volume, 2010
  • Japan, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • Japan, Total Hemostasis Test Volume By Market Segment, 2010-2020
  • Japan, All Market Segments Hemostasis Test Volume, 2010-2020
  • Japan, Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • Japan, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • Japan, Hemostasis Reagent Market By Market Segment, 2010-2020
  • Japan, Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • Japan, Hemostasis Instrument Market By Market Segment, 2010-2020
  • Japan, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • Japan, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • Japan, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • Japan, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • Japan, Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
  • Executive Summary Table: Spain, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • Spain, Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • Spain, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • Spain, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • Spain, Hospital Laboratories Average Daily Test Volume, 2010
  • Spain, Ambulatory Care Centers Average Daily Test Volume, 2010
  • Spain, Commercial/Private Laboratories Average Daily Test Volume, 2010
  • Spain, Total Hemostasis Test Volume By Market Segment, 2010-2020
  • Spain, All Market Segments Hemostasis Test Volume, 2010-2020
  • Spain, Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • Spain, Ambulatory Care Centers Hemostasis Test Volume, 2010-2020
  • Spain, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • Spain, Hemostasis Reagent Market By Market Segment, 2010-2020
  • Spain, Major Suppliers of Hemostasis Reagents, Estimated Sales and Market Shares, 2010
  • Spain, Hemostasis Instrument Market By Market Segment, 2010
  • Spain, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • Spain, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • Spain, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • Spain, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • Spain, Major Suppliers of Hemostasis Diagnostic Products, Estimates Sales and Market Shares, 2010
  • xecutive Summary Table: U.K., Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • U.K., Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • U.K., Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • U.K., Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • U.K., Hospital Laboratories Average Daily Test Volume, 2010
  • U.K., Commercial/Private Laboratories Average Daily Test Volume, 2010
  • U.K., Total Hemostasis Test Volume By Market Segment, 2010-2020
  • U.K., All Market Segments Hemostasis Test Volume, 2010-2020
  • U.K., Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • U.K., Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • U.K., Hemostasis Reagent Market By Market Segment, 2010-2020
  • U.K., Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • U.K., Hemostasis Instrument Market By Market Segment, 2010
  • U.K., Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • U.K., Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • U.K., Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • U.K., Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • U.K., Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
  • Executive Summary Table: U.S.A., Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
  • U.S.A., Laboratories Performing Hemostasis Tests By Market Segment, 2010
  • U.S.A., Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
  • U.S.A., Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
  • U.S.A., Physician Offices/Group Practices Performing Hemostasis Tests By Practice Size, 2010
  • U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
  • U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
  • U.S.A., Physician Offices/Group Practices Average Daily Test Volume
  • U.S.A., Total Hemostasis Test Volume By Market Segment, 2010-2020
  • U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020
  • U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020
  • U.S.A., Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
  • U.S.A., Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
  • U.S.A., Hemostasis Reagent Market By Market Segment, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Reagents Estimated Sales and Market Shares, 2010
  • U.S.A., Hemostasis Instrument Market By Market Segment, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
  • U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
  • U.S.A., Total Hemostasis Diagnostics Market By Product Category, 2010-2020
  • U.S.A., Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
Back to Top